Attri M, Raghav A, Sinha J
CNS Neurol Disord Drug Targets. 2024; 24(2):115-131.
PMID: 39323347
DOI: 10.2174/0118715273329531240911075309.
Versijpt J, Deligianni C, Hussain M, Amin F, Reuter U, Sanchez-Del-Rio M
J Headache Pain. 2024; 25(1):119.
PMID: 39044170
PMC: 11267726.
DOI: 10.1186/s10194-024-01826-y.
Kowacs P, Sampaio Rocha-Filho P, Peres M, Edvinsson L
Arq Neuropsiquiatr. 2023; 81(12):1084-1097.
PMID: 38157876
PMC: 10756794.
DOI: 10.1055/s-0043-1777723.
Rubio-Beltran E, Schoon R, van den Berg J, Schuiling-Veninga C, Koch B, Villalon C
Ann Clin Transl Neurol. 2022; 9(9):1405-1416.
PMID: 36029132
PMC: 9463958.
DOI: 10.1002/acn3.51640.
Rincon D, Doerr M, Daza M
ACS Omega. 2021; 6(32):20992-21004.
PMID: 34423207
PMC: 8375099.
DOI: 10.1021/acsomega.1c02559.
Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?.
Papetti L, Ursitti F, Moavero R, Ferilli M, Sforza G, Tarantino S
Front Neurol. 2019; 10:771.
PMID: 31379721
PMC: 6646427.
DOI: 10.3389/fneur.2019.00771.
Beta-Blockers for Migraine Prevention: a Review Article.
Danesh A, Gottschalk P
Curr Treat Options Neurol. 2019; 21(4):20.
PMID: 30903383
DOI: 10.1007/s11940-019-0556-3.
Propranolol: A 50-Year Historical Perspective.
Srinivasan A
Ann Indian Acad Neurol. 2019; 22(1):21-26.
PMID: 30692755
PMC: 6327687.
DOI: 10.4103/aian.AIAN_201_18.
S-propranolol protected H9C2 cells from ischemia/reperfusion-induced apoptosis via downregultion of RACK1 Gene.
Jia X, Zhang L, Mao X
Int J Clin Exp Pathol. 2015; 8(9):10335-44.
PMID: 26617741
PMC: 4637556.
Can topical beta blockers be successful for acute migraine management?.
Chung S
Mo Med. 2014; 111(4):294-6.
PMID: 25211854
PMC: 6179464.
A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E, Mashouf M
Paediatr Drugs. 2010; 12(4):269-75.
PMID: 20593910
DOI: 10.2165/11316270-000000000-00000.
P3MC: a double blind parallel group randomised placebo controlled trial of Propranolol and Pizotifen in preventing migraine in children.
Silcocks P, Whitham D, Whitehouse W
Trials. 2010; 11:71.
PMID: 20553601
PMC: 2903577.
DOI: 10.1186/1745-6215-11-71.
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.
Naegel S, Obermann M
Neuropsychiatr Dis Treat. 2010; 6:17-28.
PMID: 20169042
PMC: 2951059.
DOI: 10.2147/ndt.s6459.
[Alternatives to beta blockers in preventive migraine treatment].
Evers S
Nervenarzt. 2008; 79(10):1135-6, 1138-40, 1142-3.
PMID: 18806984
DOI: 10.1007/s00115-008-2522-2.
Current and prospective pharmacological targets in relation to antimigraine action.
Mehrotra S, Gupta S, Chan K, Villalon C, Centurion D, Saxena P
Naunyn Schmiedebergs Arch Pharmacol. 2008; 378(4):371-94.
PMID: 18626630
DOI: 10.1007/s00210-008-0322-7.
The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension.
Sica D, Neutel J, Weber M, Manowitz N
J Clin Hypertens (Greenwich). 2004; 6(5):231-41.
PMID: 15133405
PMC: 8109330.
DOI: 10.1111/j.1076-7460.2004.3624.x.
The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockers.
Limmroth V, Michel M
Br J Clin Pharmacol. 2001; 52(3):237-43.
PMID: 11560555
PMC: 2014548.
DOI: 10.1046/j.0306-5251.2001.01459.x.
A review of the treatment of primary headaches. Part I: Migraine.
Leone M, Grazzi L, DAmico D, Moschiano F, Bussone G
Ital J Neurol Sci. 1995; 16(9):577-86.
PMID: 8838783
DOI: 10.1007/BF02230907.
Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba.
Grandjean T, RIVIER J
Br Heart J. 1968; 30(1):50-9.
PMID: 5637558
PMC: 459207.
DOI: 10.1136/hrt.30.1.50.
Haemodynamic effects of beta-adrenergic blockade.
AStrom H
Br Heart J. 1968; 30(1):44-9.
PMID: 5637556
PMC: 459206.
DOI: 10.1136/hrt.30.1.44.
